Member
Keylicon Biosciences
Keylicon Biosciences focuses on developing durable RNA-based vaccines and therapies utilizing a next-generation self-amplifying RNA platform. The company pursues advanced solutions for prolonging the effectiveness of RNA therapeutics and vaccines.
Industries
N/A
Expertise Areas
- Durable RNA therapeutics
- RNA vaccine research and development
Key Technologies
- Self-amplifying RNA